In line with tumor stroma interactions potentially playing a prognostic role, integrin pathway and chemokine signaling genes were found upregulated in stroma-rich poor-prognosis tumors, further supported by previous observation of CXCR4 and CXCR7 being upregulated in aggressive disease [322]. This evidence concerns the gene CXCR4 and neoplasm.